Bruker Corporation (BRKR)

Market Cap	6.23B -19.6%
Revenue (ttm)	3.44B +2.1%
Net Income	-22.50M
EPS	-0.15
Shares Out	151.94M
PE Ratio	n/a
Forward PE	19.35
Dividend	$0.20 (0.49%)
Ex-Dividend Date	Dec 8, 2025

Volume	2,837,127
Open	39.89
Previous Close	39.89
Day's Range	39.49 - 41.50
52-Week Range	28.53 - 56.22
Beta	1.18
Analysts	Buy
Price Target	49.54 (+20.77%)
Earnings Date	Feb 12, 2026

About BRKR

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 4, 2000
• Employees: 11,396
• Stock Exchange: NASDAQ
• Ticker Symbol: BRKR
• Website: https://www.bruker.com

Analyst Summary

According to 13 analysts, the average rating for BRKR stock is "Buy." The 12-month stock price target is $49.54, which is an increase of 20.77% from the latest price.

Price Target

$49.54

(20.77% upside)

Analyst Consensus: Buy